Ignite Creation Date:
2025-12-24 @ 12:20 PM
Ignite Modification Date:
2025-12-27 @ 9:35 PM
Study NCT ID:
NCT02212561
Status:
COMPLETED
Last Update Posted:
2020-03-26
First Post:
2014-07-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome
Sponsor:
St. Jude Children's Research Hospital
Organization: